These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose. Nakayama K; Koike H; Oshima T; Hashimoto K Jpn J Pharmacol; 1973 Feb; 23(1):9-16. PubMed ID: 4146270 [No Abstract] [Full Text] [Related]
14. Antiarrhythmic actions of BC 105. Ahmad M; Achari G Jpn J Pharmacol; 1969 Mar; 19(1):19-24. PubMed ID: 5306219 [No Abstract] [Full Text] [Related]
15. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat. Diederich KW; Boyksen D Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225 [No Abstract] [Full Text] [Related]
16. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124]. Fujita T; Miyazaki M Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862 [No Abstract] [Full Text] [Related]
17. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)]. Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153 [TBL] [Abstract][Full Text] [Related]
18. Compounds related to 4-disopropylamino-2-phenyl-2(2-pyridyl)butyramide. Their synthesis and antiarrhythmic activity. Yen CH; Lowrie HS; Dean RR J Med Chem; 1974 Nov; 17(11):1131-5. PubMed ID: 4412561 [No Abstract] [Full Text] [Related]
19. Ventricular fibrillation and catecholamine responses during profound hypothermia in dogs. Warner WA; Anton AH; Andersen TW; Swofford LJ Anesthesiology; 1970 Jul; 33(1):43-51. PubMed ID: 4393416 [No Abstract] [Full Text] [Related]